Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Tarnow

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Journal of Human Hypertension|April 18, 2014
Low-dose spironolactone reduces plasma fibulin-1 levels in patients with type 2 diabetes and resistant hypertensionC S Oxlund, C Cangemi, J E Henriksen, et al.
Diabetes, Obesity & Metabolism|March 30, 2007
Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trialS S Lund, L Tarnow, C D A Stehouwer, et al.
Immunobiology|May 9, 2020
Association between severe diabetic retinopathy and lectin pathway proteins - an 18-year follow-up study with newly diagnosed type 1 diabetes patientsC B Holt, I T Hoffmann-Petersen, T K Hansen, et al.
Kidney International|March 14, 2008
Time course of the antiproteinuric and antihypertensive effects of direct renin inhibition in type 2 diabetesF Persson, P Rossing, K J Schjoedt, et al.
Diabetes|March 31, 1998
Predisposition to essential hypertension and development of diabetic nephropathy in IDDM patientsJ A Fagerudd, L Tarnow, P Jacobsen, et al.
Diabetologia|July 4, 2012
Higher plasma high-mobility group box 1 levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12 year follow-up studyJ W M Nin, I Ferreira, C G Schalkwijk, et al.
Diabetologia|December 24, 2004
Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathyM Saraheimo, C Forsblom, T K Hansen, et al.
Diabetes|December 2, 1999
Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillariesC G Schalkwijk, N Ligtvoet, H Twaalfhoven, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 19, 2017
Comparing effects of insulin analogues and human insulin on nocturnal glycaemia in hypoglycaemia-prone people with Type 1 diabetesP L Kristensen, L Tarnow, C Bay, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 27, 2007
Endothelial dysfunction and low-grade inflammation and the progression of retinopathy in Type 2 diabetesA M W Spijkerman, M-A Gall, L Tarnow, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Journal of Human Hypertension|April 18, 2014
Low-dose spironolactone reduces plasma fibulin-1 levels in patients with type 2 diabetes and resistant hypertensionC S Oxlund, C Cangemi, J E Henriksen, et al.
Diabetes, Obesity & Metabolism|March 30, 2007
Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trialS S Lund, L Tarnow, C D A Stehouwer, et al.
Immunobiology|May 9, 2020
Association between severe diabetic retinopathy and lectin pathway proteins - an 18-year follow-up study with newly diagnosed type 1 diabetes patientsC B Holt, I T Hoffmann-Petersen, T K Hansen, et al.
Kidney International|March 14, 2008
Time course of the antiproteinuric and antihypertensive effects of direct renin inhibition in type 2 diabetesF Persson, P Rossing, K J Schjoedt, et al.
Diabetes|March 31, 1998
Predisposition to essential hypertension and development of diabetic nephropathy in IDDM patientsJ A Fagerudd, L Tarnow, P Jacobsen, et al.
Diabetologia|July 4, 2012
Higher plasma high-mobility group box 1 levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12 year follow-up studyJ W M Nin, I Ferreira, C G Schalkwijk, et al.
Diabetologia|December 24, 2004
Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathyM Saraheimo, C Forsblom, T K Hansen, et al.
Diabetes|December 2, 1999
Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillariesC G Schalkwijk, N Ligtvoet, H Twaalfhoven, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 19, 2017
Comparing effects of insulin analogues and human insulin on nocturnal glycaemia in hypoglycaemia-prone people with Type 1 diabetesP L Kristensen, L Tarnow, C Bay, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 27, 2007
Endothelial dysfunction and low-grade inflammation and the progression of retinopathy in Type 2 diabetesA M W Spijkerman, M-A Gall, L Tarnow, et al.
Pageof 11